CD69 and liver cancer: Consistent with this, in another cohort of liver cancer patients, we used flow cytometry and found higher levels of CD69+CD8+T cells and GZMB of CD8+T in the MUC1 high group, but did not find a statistical difference in CD8+T cells which may be related to sample size.